Skip to main content
. 2021 Feb 19;9:19–25. doi: 10.5414/CNCS110407

Table 1. Treatment of transplant renal vein thrombosis, in the first 2 weeks. Literature review.

Author Case report Time to ARVT Risk factors Treatment Treatment time Outcome
Rerolle et al. [8] Case 1 POD 8 Right kidney, cold ischemia time 40 hours, ISS with MMF and CsA; delayed graft function; PT thromboaspiration followed by full heparinization; Immediately Restored satisfactory vein patency (20 min). SCr at 6 months was 2 mg/dL.
Case 2 POD 12 Right kidney, cold ischemia time 30 hours 30 minutes; DGF; ISS with CsA; PT thromboaspiration followed by full heparinization; Immediately Restored satisfactory vein patency (20 minutes). SCr at 6 months was 1.4 mg/dL.
Lerman et al. [21] Case 1 ND but until POD 15 ISS with MMF, no other was reported inclusive aberrant venous anatomy Graft explanted and flushed with preservation solution and TPA followed by clot removal (renal and iliac vein), graft reimplantation and full heparinization. After 1 day Early allograft dysfunction because of significant tubular damage, however, at 17 weeks after renal vein thrombectomy SCr was 1.74 mg/dL.
Hori et al. [22] Case 1 Uncertain
POD 1 – 4
BMI 33.4 kg/m2, IMS with MMF, hematoma Surgical thrombectomy POD 4 POD 10 SCr ≈ 1.5 mg/dL
Fathi et al. [20] Case 1 POD 0 Hematoma Surgery thrombectomy and evacuated hematoma Immediately Functioning graft for more than 4 years
Case 2 POD 2 ND Surgical thrombectomy Immediately Functioning graft for more than 6 months
Kawano et al. [7] Case 1 POD 10 Cold ischemia time 24 hours 42 minutes; ISS with MMF Surgical approach: infusion with Euro-Collins solution by RA resulting in output vein thrombi followed by systemic heparinization Immediately Recovered urine output and kidney function after 1 week

BMI = body mass index; CsA = cyclosporine; DGF = delayed graft function; ISS = immunosuppressive treatment; MMF = mycophenolate mofetil; ND = not defined; POD = postoperative day; PT = percutaneous transluminal; RA = renal artery; SCr = serum creatinine; TPA = tissue plasminogen activator; ARVT = transplant renal vein thrombosis.